The Greatest Guide To pentobarbital sodium contraindications
The Greatest Guide To pentobarbital sodium contraindications
Blog Article
pentobarbital will decrease the level or effect of phenytoin by affecting hepatic enzyme CYP2C9/ten metabolism. Use Warning/Observe.
DESCRIPTION The barbiturates are nonselective central anxious system depressants which can be largely used as sedative hypnotics and likewise anticonvulsants in subhypnotic doses. The barbiturates as well as their sodium salts are matter to control beneath the Federal Controlled Substances Act (See “Drug Abuse and Dependence” section). The sodium salts of amobarbital, pentobarbital, phenobarbital, and secobarbital can be found as sterile parenteral solutions. Barbiturates are substituted pyrimidine derivatives by which the basic structure popular to these drugs is barbituric acid, a substance that has no central anxious procedure (CNS) exercise.
pentobarbital will minimize the extent or effect of docetaxel by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Minimal/Importance Unidentified.
buprenorphine, very long-acting injection and pentobarbital each enhance sedation. Stay away from or Use Alternate Drug. Restrict use to individuals for whom alternative therapy options are insufficient
Money punishment opponents say This can be problematic due to the fact a bad batch of the drug, or poor use may lead to botched executions that result in pain right before Demise.
pentobarbital will lessen the level or effect of bedaquiline by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Steer clear of or Use Alternate Drug. Steer clear of coadministration of bedaquiline with solid CYP3A4 inducers due to potential for reduced therapeutic effect
pentobarbital will decrease the level or effect of tamoxifen by affecting hepatic enzyme CYP2C9/ten metabolism. Use Caution/Keep here track of.
pentobarbital will decrease the level or effect of fostemsavir by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Contraindicated.
pentobarbital will decrease the extent or effect of artemether/lumefantrine by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Steer clear of or Use Alternate Drug. Coadministration with strong CYP3A4 inducers can result in lessened serum concentrations and loss of antimalarial efficacy
pentobarbital will decrease the extent or effect of donepezil by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Slight/Importance Unknown.
pentobarbital will minimize the level or effect of lonafarnib by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Contraindicated. Lonafarnib is usually a delicate CYP3A4 substrate. Coadministration with robust or average CYP3A4 inducers is contraindicated.
pentobarbital will lower the extent or effect of rabeprazole by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Not known.
pentobarbital will lessen the level or effect of atazanavir by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Small/Significance Mysterious.
pentobarbital decreases amounts of ponatinib by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Keep away from or Use Alternate Drug. Keep away from Except if the coadministration outweighs the attainable threat of ponatinib underexposure; keep an eye on for signs of reduced efficacy.